The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

The prostate-specific membrane antigen (PSMA) has received increased consideration during the past few years as an excellent target for both imaging and therapy of prostate cancer. After many years of outstanding preclinical research, the first significant step forward in clinical use was achieved i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Nuclear Medicine 2016-10, Vol.57 (Suppl 3), p.79S-89S
Hauptverfasser:	Afshar-Oromieh, Ali, Babich, John W, Kratochwil, Clemens, Giesel, Frederik L, Eisenhut, Michael, Kopka, Klaus, Haberkorn, Uwe
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens, Surface - metabolism Dipeptides - pharmacokinetics Dipeptides - therapeutic use Evidence-Based Medicine Glutamate Carboxypeptidase II - antagonists & inhibitors Glutamate Carboxypeptidase II - metabolism Heterocyclic Compounds, 1-Ring - pharmacokinetics Heterocyclic Compounds, 1-Ring - therapeutic use Humans Image Enhancement Male Molecular Diagnostic Techniques Molecular Targeted Therapy Organotechnetium Compounds - pharmacokinetics Organotechnetium Compounds - therapeutic use Positron-Emission Tomography Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - metabolism Prostatic Neoplasms - radiotherapy Radiopharmaceuticals
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!